SECONDARY EXPPOSURE TO ANDROGEL ALERT

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Secondary Exposure to AndroGel Can Cause Various Irregularities in Women and Children

Black-Box Warning Issued By the FDA for Secondary Exposure to AngroGel in Women and Children

If you or a family member has experienced secondary exposure to AndroGel and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM
  • Our firm is vigorously pursuing this matter.
  • Our clients have received millions of dollars in lawsuits involving defective drugs.
  • No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit

About Secondary Exposure to AndroGel

AndroGel is used to treat low testosterone (“Low T”) and is prescribed as a testosterone-replacement drug, mostly to men who cannot produce enough amounts of the male hormone. It is a synthetic hormone in gel form that is absorbed through the skin and increases the total amount of testosterone in the body to a normal range.

AndroGel contains a Black-Box warning for secondary exposure to women and children. This warning states that women and children should avoid contact with any unwashed application sites or unwashed clothing of men using the drug. Women and children may show symptoms of secondary exposure to AndroGel including:

  • Enlargement of genitals
  • Early development of pubic hair in children
  • Increased erections
  • Increased libido
  • Aggressive behavior
  • Advanced bone age in children
  • Increased acne and body hair in women